All In Biotech

Drug Trial Radar · NCT02765009

Effects of Fluid Balance Control in Critically Ill Patients

Effects of Fluid Balance Control in Critically Ill Patients: A Multicenter Randomized Study

Last checked: Nov 19, 2026Latest source record: Sep 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,411 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,411

Actual

Start

Jun 1, 2016

Primary completion

Jul 31, 2019

Study completion May 25, 2020

Sponsor

Lead sponsor
Central Hospital, Nancy, FranceAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ministry of Health, France
First posted
May 6, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Most ICU patients develop a positive fluid balance, mainly during the two first weeks of their stay. The causes are multifactorial: a reduced urine output subsequent to shock state, positive pressure mechanical ventilation, acute renal failure, post-operative period of major surgical procedures, and simultaneous fluid loading to maintain volemia and acceptable arterial pressure. Additionally, the efficacy of fluid loading is frequently suboptimal, in relation to severe hypoalbuminemia and inflammatory capillary leakage. This results usually in a cumulated positive fluid balance of more than 10 litres at the end of the first week of stay. A high number of studies have showed that such a positive fluid balance was an independent factor of worse prognosis in selected populations of ICU patients: acute renal failure, acute respiratory distress syndrome (ARDS), sepsis, post-operative of high risk surgery. However, little is known about the putative causal role of positive fluid balance by itself on outcome. However, in two randomized controlled studies in patients with ARDS, a strategy of fluid balance control has been demonstrated to reduce time under mechanical ventilation and ICU length of stay with no noticeable adverse effects. Although avoiding fluid overload is now recommended in ARDS management, there is no evidence that this approach would be beneficial in a more general population of ICU patients (i.e. with sepsis, acute renal failure, mechanical ventilation). In addition, fluid restriction -mainly if applied early could be deleterious in reducing both tissue oxygen delivery and perfusion pressure. There is a place for a prospective study comparing a "conventional" attitude based on liberal fluid management throughout the ICU stay with a restrictive approach aiming at controlling fluid balance, at least as soon as the patient circulatory status is stabilized. The latter approach would use a simple algorithm using fluid restriction and diuretics based on daily weighing, a common procedure in the ICU, probably more reliable than cumulative measurement of fluid movements in patients whose limits have been underlined.

Conditions

  • Fluid Shifts
  • Critical Care

Interventions

  • diureticsDrug

    Used to reduce fluid overload as evidenced by weight gain

  • albuminDrug

    Used to reduce fluid overload in addition with diuretics in hypoalbuminemic patients

  • fluid restrictionOther

    Used to reduce fluid overload

  • renal replacementDevice

    Used to reduce fluid overload in patients with renal replacement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause mortality at 60 days after inclusionTime frame: 60 days

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Hopital Nord Franche-Comté

    Belfort, France

  • Centre Hospitalier Universitaire

    Dijon, France

  • Centre Hospitalier Universitaire

    Lyon, France

  • Centre Hospitalier Régional

    Metz, France

  • Centre Hospitalier Régional et Universitaire

    Nancy, France

  • Groupe Hospitalier Saint Joseph

    Paris, France

  • Centre Hospitalier intercommunal

    Poissy, France

  • Centre Hospitalier Régional et Universitaire

    Strasbourg, France

  • CentreHospitalier Régional et universitaire

    Strasbourg, France

  • Centre Hospitalier Régional

    Thionville, France

  • Centre Hospitalier

    Verdun, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.